Activity of the Highly Specific RET Inhibitor Selpercatinib (LOXO-292) in Pediatric Patients With Tumors Harboring RET Gene Alterations

Detalles Bibliográficos
Autores principales: Ortiz, Michael V., Gerdemann, Ulrike, Raju, Sandya Govinda, Henry, Dahlia, Smith, Steve, Rothenberg, S. Michael, Cox, Michael C., Proust, Stéphanie, Bender, Julia Glade, Frazier, A. Lindsay, Anderson, Peter, Pappo, Alberto S.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: American Society of Clinical Oncology 2020
Materias:
Case Reports
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7450975/
https://www.ncbi.nlm.nih.gov/pubmed/32923911
http://dx.doi.org/10.1200/PO.19.00401

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7450975/
https://www.ncbi.nlm.nih.gov/pubmed/32923911
http://dx.doi.org/10.1200/PO.19.00401

Ejemplares similares